EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access

A case of mineralocorticoid intermediate-producing sarcomatoid adrenal cortical carcinoma: case report and review of literature

Maki Kanzawa, Miki Watanabe, Masaaki Yamamoto, Tomoko Nishigaki, Masaki Suzuki, Hidenori Fukuoka, Tomoaki Terakawa, Katsumi Shigemura, Hiroki Shimada, Yasuhiro Nakamura, Wataru Ogawa, Tomoo Itoh

Endocrine Journal · 2025

DOI: 10.1507/endocrj.ej24-0687 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrine Journal, 2025. Verfasst von Maki Kanzawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan. Hauptthemen laut MEDLINE: Adrenocortical Carcinoma, Adrenal Cortex Neoplasms, Mineralocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcomatoid adrenal cortical carcinoma (SACC) is an extremely rare histological subtype accounting for only 0.2% of all adrenal cortical carcinomas. Most reported cases of SACC are nonfunctional, showing a biphasic histological pattern with both epithelial adrenocortical carcinoma and sarcomatous components, which are often associated with poor prognosis. Herein, we report a unique case of SACC with characteristics distinct from those previously documented. A 66-year-old man presented with uncontrolled hypertension, night sweats, exertional dyspnea, and palpitations. Imaging revealed an 11 cm mass in the left adrenal gland. Laboratory results indicated hypokalemia with suppressed plasma renin and aldosterone levels and the presence of mineralocorticoid intermediates, notably elevated deoxycorticosterone (DOC), detected via LC-MS/MS. The patient underwent a left adrenalectomy. Histologically, the tumor consisted solely of spindle cells without the typical adrenocortical carcinoma components. Immunohistochemical analysis demonstrated partial positivity for steroidogenic enzymes, including 3β-hydroxysteroid dehydrogenase, cytochrome P450 family 21 subfamily A member 2 (CYP21A2) and cytochrome P450 family 11 subfamily B member 1 (CYP11B1). This finding was consistent with RNA expression analysis, supporting the synthesis of mineralocorticoid intermediates within the tumor. However, the discrepancy between the measured steroid intermediate metabolites and enzyme expression patterns in the tumor, as indicated by immunostaining and mRNA levels, suggests that the steroid production pathway in this tumor remains partially unclear. Two years postoperatively, the patient has remained free from recurrence or metastasis. This case holds particular value, as it is the first report to describe hormone production in a SACC composed solely of spindle cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenocortical CarcinomaAdrenal Cortex NeoplasmsMineralocorticoidsHumansMaleAgedAdrenal CortexAdrenalectomyImmunohistochemistry3-Hydroxysteroid DehydrogenasesSteroid 21-HydroxylaseSteroid 11-beta-Hydroxylase

Stichwörter der Autor:innen

11-DeoxycorticosteroneMineralocorticoid intermediateSarcomatoid adrenal cortical carcinomaSpindle cellsSteroidogenic factor-1

Substanzen

Mineralocorticoids3-Hydroxysteroid DehydrogenasesSteroid 21-HydroxylaseSteroid 11-beta-Hydroxylase

Autor:innen und Institutionen

  • Department of Diagnostic Pathology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan.
  • Department of Diagnostic Pathology, Kobe University Hospital, Kobe, Japan.
  • Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Hospital, Kobe, Japan.
  • Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kanzawa, M., Watanabe, M., Yamamoto, M., Nishigaki, T., Suzuki, M., Fukuoka, H., Terakawa, T., Shigemura, K., Shimada, H., Nakamura, Y., Ogawa, W., & Itoh, T. (2025). A case of mineralocorticoid intermediate-producing sarcomatoid adrenal cortical carcinoma: case report and review of literature. Endocrine Journal. https://doi.org/10.1507/endocrj.ej24-0687

Vancouver

Kanzawa M, Watanabe M, Yamamoto M, Nishigaki T, Suzuki M, Fukuoka H, et al. A case of mineralocorticoid intermediate-producing sarcomatoid adrenal cortical carcinoma: case report and review of literature. Endocrine Journal. 2025. doi:10.1507/endocrj.ej24-0687

BibTeX
@article{Kanzawa2025,
  author = {Kanzawa, Maki and Watanabe, Miki and Yamamoto, Masaaki and Nishigaki, Tomoko and Suzuki, Masaki and Fukuoka, Hidenori and Terakawa, Tomoaki and Shigemura, Katsumi and Shimada, Hiroki and Nakamura, Yasuhiro and Ogawa, Wataru and Itoh, Tomoo},
  title = {A case of mineralocorticoid intermediate-producing sarcomatoid adrenal cortical carcinoma: case report and review of literature},
  journal = {Endocrine Journal},
  year = {2025},
  doi = {10.1507/endocrj.ej24-0687}
}
Kostenlos starten →